A Macro View of Microdosing

April 13, 2022

Microdosing psychedelics involves consuming doses that are one-twentieth to one-tenth the size of standard doses. The practice has become increasingly popular among individuals seeking to boost their productivity, elevate their mood, or treat symptoms of depression, anxiety, or pain. The increasing use of microdosing has inspired media coverage and scientific analysis of its costs and benefits. On April 13, POPLAR gathered experts on the science, law, and business of microdosing for a panel discussion accompanied by a digital symposium on the Bill of Health. After a keynote address by Dr. James Fadiman, a longtime microdosing scholar and advocate, the event turned to a panel discussion of the promise, risks, and future of microdosing psychedelics.

Learn more at https://petrieflom.law.harvard.edu/events/details/a-macro-view-of-microdosing
Be the first to comment